Industry NewsCEDARVILLE Engineering Group & Rockland Immunochemicals, Inc. Collaborate on a 3D Bioprinting Discovery Project
Industry NewsFormula Pharmaceuticals and Rockland Immunochemicals Enter into a Collaboration to Develop C.I.K. CAR™ Immunotherapy Pipeline for the Treatment of Cancer
Product NewsRockland Immunochemicals, Inc. Introduces Melanoma Cell Lines in Collaboration with The Wistar Institute
Industry NewsRockland Hosts Meeting on STEM Job Creation with PA Officials and Regional Organizations
Industry NewsThe Wistar Institute and Rockland Immunochemicals Announce Partnership in Discovery and Research
Industry NewsRockland Immunochemicals to Develop Synthetic Antibodies for Modified RNA Detection and Quantitation with $225,000 SBIR Funded Grant
Industry NewsRockland Immunochemicals, Inc. Awarded SBIR Funding to Develop Antibody-Based Point of Care Device for the Diagnosis of Sickle Cell Disease
Product NewsRockland Immunochemicals announces the successful use of a number of its antibody reagents on clinical samples in studies being conducted by the Swedish Human Protein Atlas program
Product NewsRockland Immunochemicals, Inc. offers over 2800 target-specific antibodies to validate knockdown protein expression
